Apatinib as First -Line Treatment for Advanced Esophagus Cancer
Clinical trial NCT03542422 · UNKNOWN
Trial details
- NCT number
- NCT03542422
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-30
- Primary completion
- 2018-12-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.